Disclosures for "Real World Treatment Patterns of Patients With Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS) in the United States (US)"
-
Dr. Kothare has nothing to disclose.
-
Mr. Gibson has received personal compensation for serving as an employee of Adelphi Real World.
-
The institution of Kelly Simontacchi has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Jazz Pharmaceuticals.
-
Ms. Viswanathan has received personal compensation for serving as an employee of Allergan plc. Ms. Viswanathan has received personal compensation for serving as an employee of Precision Medicine Group. Ms. Viswanathan has received stock or an ownership interest from Allergan plc. Ms. Viswanathan has received stock or an ownership interest from Precision Medicine Group.
-
Dr. Thomas has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Thomas has stock in Jazz Pharmaceuticals.
-
Miss Connolly has received personal compensation for serving as an employee of Adelphi Real World.
-
Jay Salpekar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Jay Salpekar has received research support from Jazz Pharmaceuticals. Jay Salpekar has received publishing royalties from a publication relating to health care.
-
Ms. Lin has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Ms. Lin has stock in Jazz Pharmaceuticals.